2021
DOI: 10.1538/expanim.20-0103
|View full text |Cite
|
Sign up to set email alerts
|

Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model

Abstract: Pazopanib is a tyrosine kinase inhibitor that is generally used for the treatment of metastatic renal cell cancer and advanced soft tissue sarcoma. It can cause various degrees of hepatotoxicity. Our study aimed to investigate the effect of taxifolin on pazopanib-induced liver toxicity. A total of 18 rats were divided into three groups: the pazopanib (PP), pazopanib plus taxifolin (TPP), and control (C) group. Taxifolin was administered to the TPP (n = 6) group with a dose of 50 mg/kg. Distilled water was oral… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 36 publications
(34 reference statements)
0
8
0
Order By: Relevance
“…No previous studies have investigated the antioxidant and anti-inflammatory effects of taxifolin on the bladder. It has been documented that taxifolin protects liver tissue from oxidative damage by inhibiting the increase in MDA and TOS and decreasing the tGSH levels and TAS values due to pazopanib, an anticancer drug [13]. Another study reported that taxifolin protected optic nerve tissue against oxidative and inflammatory damage of the platinum-derived anticancer drug [34].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…No previous studies have investigated the antioxidant and anti-inflammatory effects of taxifolin on the bladder. It has been documented that taxifolin protects liver tissue from oxidative damage by inhibiting the increase in MDA and TOS and decreasing the tGSH levels and TAS values due to pazopanib, an anticancer drug [13]. Another study reported that taxifolin protected optic nerve tissue against oxidative and inflammatory damage of the platinum-derived anticancer drug [34].…”
Section: Discussionmentioning
confidence: 99%
“…To implement this experiment, the TCYC group (n = 6) was given 50 mg/kg of taxifolin orally by gavage. This dose of taxifolin has been used in animals before and has been found to be effective against oxidative liver damage [13]. Normal saline (0.9% NaCl) was used as the solvent for the CYC (n = 6) and HC (n = 6) groups.…”
Section: Experiments Proceduresmentioning
confidence: 99%
“…Within the scope of the experiment, the TACR (n = 12) rat group was given 50 mg kgG 1 of taxifolin by oral gavage into their stomach 16,17 . The same volume of distilled water was applied to the ACR (n = 12) and HG (n = 12) groups by gavage.…”
Section: Methodsmentioning
confidence: 99%
“…Experiment procedure A total of 50 mg/kg taxifolin 14 was administered orally to the stomach of rats by gavage in the TMTX group (n=6). Normal saline (0.9% NaCl) was applied to rats in MTX (n=6) and healthy (n=6) groups as solvent by the same method.…”
Section: Experimental Groupsmentioning
confidence: 99%